Scientists interviewed 17 patients who reported feeling unmoored by a disease that has stripped away their sense of control ...

A Phase 2 clinical trial testing obexelimab in adults with relapsing types of multiple sclerosis is now recruiting ...

Remitting Multiple Sclerosis, was 'rammed' by someone while on a cruise, despite using a wheelchair and the lady knowing ...

The following is a summary of “Cost–consequence analysis of early vs. delayed natalizumab use in highly active ...

From there, his five-year £500,000 fundraising challenge, Source2Sea, was born. "In essence, it's a series of expeditions ...

There are relapsing-remitting and progressive types of MS, but the course is rarely predictable. Researchers still don’t fully understand the cause of MS or why the rate of progression is so ...

Relapsing-remitting multiple sclerosis is a type of multiple sclerosis in which you experience relapses of the disease with periods of remission occurring in between. Relapsing-remitting multiple ...

Common tools MS patients use to improve their quality of life include wheelchairs, canes, leg braces, and some medical treatments called disease-modifying therapies (DMTs). Relapsing-remitting MS ...

Frexalimab is under clinical development by Sanofi and currently in Phase II for Relapsing Remitting Multiple Sclerosis (RRMS). According to GlobalData, Phase II drugs for Relapsing Remitting Multiple ...

This mechanism of action provides the rationale for use in relapsing–remitting multiple sclerosis (MS) in a short-course annual dosing regimen. Based on the results of a pivotal Phase III study ...